Introduction: Ketorolac is used to treat eye pain and to relieve the itchiness and burning of seasonal allergies. Fluorometholone is a synthetic glucocorticoid used for treating eye inflammatory diseases. A simultaneous and new RP-HPLC method was developed for the estimation of Ketorolac tromethamine and Fluorometholone in ophthalmic solutions using Hydrochlorothiazide as an internal standard. Materials and Methods: Shimadzu Model CBM-20A/20 Alite with phenomenex C8 column (250 mm × 4.6 mm i.d., 5 µm particle size) was used for the chromatographic study. 0.1 % acetic acid and methanol (20: 80, v/v) mixture was used as mobile phase with flow rate 0.7 ml/min and UV detection at 241 nm. Results and Discussion: Linearity was observed over the concentration range 1-100 μg/ml with regression equation y = 0.1047x + 0.0006 and correlation coefficient 0.9993 and the method was validated as per ICH guidelines. Conclusions: The method is more precise and accurate and suitable for the quality control analysis of combined formulations of Fluorometholone and Ketorolac tromethamine.
INTRODUCTION
F luorometholone (FLM) [1] [ Figure 1a ] is also known as 6α-methyl-9α-fluoro-11β,17α-dihydroxypregna-1,4-diene-3,20-dione, and is a synthetic glucocorticoid which is used in the treatment of inflammatory eye diseases. FLM (CAS No. 426-13-1), it has a molecular formula, C 22 H 29 FO 4 and molecular 376.462 g/mol (pKa 12.65). It is used in the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. FLM is available with brand names Efflumidex, Flucon, FML Forte, etc.
Ketorolac tromethamine (KT) [2] [ Figure 1b ] is chemically known as (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid with molecular formula, C 15 H 13 NO 3 and molecular weight 255.27 g/mol. KT (CAS No. 74103-06-3) is freely soluble in methanol with pKa 3.5. Ketorolac acts by inhibiting the bodily synthesis of prostaglandins. An ophthalmic solution of ketorolac is available and is used to treat eye pain and to relieve the itchiness and burning of seasonal allergies. The primary mechanism of action responsible for Ketorolac's antiinflammatory, antipyretic, and analgesic effects is the inhibition of prostaglandin synthesis by competitive blocking ORIGINAL ARTICLE Annapurna, et al.: Liquid chromatographic method for the simultaneous determination of ketorolac tromethamine and fluorometholone
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of the enzyme cyclooxygenase. KT is available with brand names Toradol, Acular, and Sprix.
Jonvel and Andermann developed a very high-performance liquid chromatographic method [3] as a major advance technique for the determination of FLM in 1983 and only three reversed-phase high-performance liquid chromatography (RP-HPLC) methods were established for the determination of KT. [4] [5] [6] [7] Till now only one liquid chromatographic method is available for the simultaneous estimation of KT and FLM in ophthalmic dosage form [8] where the authors have used the mobile phase phosphate buffer:methanol (70:30) with pH adjustment to 3.0 and very low linearity range (2.5-7.5 µg/ml for FLM and 12.5-37.5 µg/ml for KT) has been observed in comparison to the present method. Two spectrophotometric methods were also reported for the simultaneous estimation of KT and FLM. [9, 10] In the present study, the authors have made an attempt to develop a simple, validated and robust liquid chromatographic method for the ophthalmic preparations, i.e., ear drops containing both KT and FLM using hydrochlorothiazide (HCTZ) as an internal standard (IS) and the method was validated as per the ICH guidelines. [11] 
MATERIALS AND METHODS

Chemicals and Reagents
The combination of FLM and KT is available with brand name Eyetrust (Neiss Labs Ltd, Mumbai) as eye drops containing FLM 0.1% and KT 0.5%. Methanol and acetic acid (AR) were purchased from Merck (India), and all chemicals are of HPLC grade.
Instrumentation
Shimadzu Model CBM-20A/20 Alite HPLC system, equipped with SPD M20A prominence photodiode array detector with phenomenex C8 column (250 mm × 4.6 mm i.d., 5 µm particle size) was employed for the entire chromatographic study. Isocratic elution was performed using 0.1% acetic acid and methanol (20:80, v/v) as mobile phase (flow rate 0.7 ml/min and UV detection at 241 nm) using HCTZ as IS. The overall run time was 10 min and the chromatographic study was performed at room temperature (25°C±2°C).
Preparation of Stock Solution
The stock solutions of FLM and KT were prepared by transferring each of accurately 25 mg in to 25 ml volumetric flasks separately in methanol (1000 μg/ml), sonicated for 20 min, and dilutions were made with mobile phase as per the requirement. All the solutions were filtered through 0.45 μm membrane filter before injection.
The stock solution of HCTZ (IS) was prepared by transferring accurately 10 mg of HCTZ into a 10 ml volumetric flask in methanol (1000 μg/ml) and 10 μg/ml HCTZ solution was used as an IS during the entire study.
Method Validation
Linearity
During the optimization of the method different mobile phase compositions, flow rates, columns were tried. The chromatogram of the blank run with the optimized conditions was shown in Figure 2a . A series of solutions (1-100 μg/ml) were prepared from the stock solution containing FLM and KT with mobile phase along with the IS, and 20 µL of each of these solutions were injected into the HPLC system. The peak area observed by FLM, KT, and HCTZ was noted from the chromatogram, and then the peak area ratio of FLM and KT to that of the IS (peak area of FLM/peak area of HCTZ) and (peak area of KT/peak area of HCTZ) was calculated. Calibration curves were drawn by taking the concentration of FLM and KT solutions on the X-axis and the corresponding peak area ratio values on the Y-axis. The limit of quantification and limit of detection measured as described in ICH guidelines. [11] 
Precision
The intraday precision of the assay method was evaluated at three concentration levels (10, 50 and 100 μg/ml) and the percentage RSD was calculated. The interday precision study was performed on three different days, i.e., day 1, day 2, and day 3 at three different concentration levels (10, 50, and 100 μg/ml) and the percentage RSD was calculated.
Accuracy
The accuracy of the assay method was evaluated in triplicate at three concentration levels (80, 100, and 120%), and the percentage recoveries were calculated. Standard addition and recovery experiments were conducted to determine the accuracy of the method for the quantification of FLM and KT in the drug product and the percentage recovery was calculated.
Robustness
The robustness of the assay method was established by introducing small changes in the optimized chromatographic conditions such as percentage of organic phase (78 and 82%), flow rate (±0.05 ml/min), and detection wavelength (239 and 243 nm). Robustness of the method was studied using 10 μg/ml of FLM and KT. 
Assay of ophthalmic solutions
The brands available in the local pharmacy store were procured, and FLM and KT were extracted with mobile phase in a volumetric flask. The contents were sonicated for 30 min, filtered and diluted with mobile phase as per the requirement. IS was added to this extracted solution just before injecting into the HPLC system, and the peak area ratio was calculated from the respective chromatograms as described earlier.
RESULTS AND DISCUSSION
The authors have established a validated RP-HPLC method (isocratic mode) for the determination of FLM and KT in ophthalmic preparations using HCTZ as an IS. The optimized method involves the mobile phase composition 0.1% acetic acid:methanol (20:80, v/v) and flow rate 0.7 mL/min where sharp peaks were eluted at 6.493 ± 0.03 min for KT, 5.878 ± 0.02 min for FLM , and 4.051 ± 0.01 min for HCTZ during the chromatographic study [ Figure 2b ]. The proposed method was validated as per the ICH guidelines. Both FLM and KT have shown linearity over the concentration range 1-100 μg/mL [ Table 1 ] with linear regression equation y = 0.5246x + 0.5759 (R 2 = 0.9993) and y = 0.1304x + 0.1047 (R 2 = 0.9995) for FLM and KT [ Figure 3 ], respectively.
The LOD and LOQ were found to be 0.2944 and 0.892 μg/mL, respectively. The percentage RSD in intraday and interday precision studies was found to be <2% indicating that the method is precise [ Table 2 ]. Good percentage recovery was observed in accuracy studies and the percentage RSD is <2.0 [Table 3 ] indicating that the method is accurate. The robustness of the method was assessed by exposing the drug solution to deliberate conditions purposely changing from the original established optimized conditions, and the percentage RSD 
CONCLUSION
The proposed RP-HPLC method was simple, precise, accurate, and robust. This validated method has shown very wide linearity in comparison to the previously published method, and at the same time, the resolution of the peaks was very good. As the work was performed in the presence of an IS, it is more accurate and suitable for the quality control analysis of pharmaceuticals, i.e., at present for the determination of FLM and KT in ophthalmic solutions. 
